Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement
NBER Working Paper No. 17174
---- Acknowledgements -----
This research was supported by Eli Lilly Inc.'s Project on Fair Prices for Pharmaceuticals. The empirical analysis uses data obtained under license from the IMS Health Incorporated MIDAS™ database. We would like to thank these sponsors for making the research possible. The conclusions and views expressed herein are not necessarily those of Eli Lilly Inc., IMS Health Inc, or the National Bureau of Economic Research. We are responsible for all conclusions and any errors.